Optigenex Performance
| OPGXDelisted Stock | USD 0.0003 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Optigenex are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Optigenex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical and fundamental indicators, Optigenex is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Optigenex |
Optigenex Relative Risk vs. Return Landscape
If you would invest 0.03 in Optigenex on September 28, 2025 and sell it today you would earn a total of 0.00 from holding Optigenex or generate 0.0% return on investment over 90 days. Optigenex is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Optigenex, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Optigenex Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Optigenex's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Optigenex, and traders can use it to determine the average amount a Optigenex's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| OPGX |
Based on monthly moving average Optigenex is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Optigenex by adding Optigenex to a well-diversified portfolio.
Optigenex Fundamentals Growth
Optigenex Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Optigenex, and Optigenex fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Optigenex Pink Sheet performance.
| Return On Asset | -0.11 | |||
| Profit Margin | (0.69) % | |||
| Operating Margin | (0.33) % | |||
| Current Valuation | 11.42 M | |||
| Price To Earning | (0.03) X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 991.25 K | |||
| Cash And Equivalents | 308 | |||
| Total Debt | 4.23 M | |||
| Book Value Per Share | (31.26) X | |||
| Earnings Per Share | (5.78) X | |||
| Total Asset | 1.9 M | |||
| Retained Earnings | (28.47 M) | |||
| Current Asset | 396 K | |||
| Current Liabilities | 8.68 M | |||
About Optigenex Performance
Evaluating Optigenex's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Optigenex has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Optigenex has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Optigenex Inc. engages in the manufacture and sale of healthy age management and beauty care products. It serves manufacturers, distributors, and retailers worldwide in the dietary supplement, as well as anti-aging topical skin care, cosmetic, and cosmeceutical market categories. Optigenex is traded on OTC Exchange in the United States.Things to note about Optigenex performance evaluation
Checking the ongoing alerts about Optigenex for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Optigenex help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Optigenex is not yet fully synchronised with the market data | |
| Optigenex has some characteristics of a very speculative penny stock | |
| Optigenex has a very high chance of going through financial distress in the upcoming years | |
| Optigenex currently holds 4.23 M in liabilities. Optigenex has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Optigenex until it has trouble settling it off, either with new capital or with free cash flow. So, Optigenex's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Optigenex sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Optigenex to invest in growth at high rates of return. When we think about Optigenex's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 991.25 K. Net Loss for the year was (685.13 K) with profit before overhead, payroll, taxes, and interest of 627.19 K. |
- Analyzing Optigenex's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Optigenex's stock is overvalued or undervalued compared to its peers.
- Examining Optigenex's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Optigenex's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Optigenex's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Optigenex's pink sheet. These opinions can provide insight into Optigenex's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Optigenex Pink Sheet
If you are still planning to invest in Optigenex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Optigenex's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |